Harnessing Phytochemicals for Brain Cancer Therapy: Insights Into Medulloblastoma and Glioblastoma Treatment
Phytochemical Analysis · 2026
DOI: 10.1002/pca.70067 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytochemical Analysis, 2026. Verfasst von Ilkay Irem Ozbek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Bogazici University, Bebek, Istanbul, Turkiye. Hauptthemen laut MEDLINE: Medulloblastoma, Glioblastoma, Phytochemicals, Brain Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 244 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bogazici University Research Fund.
Abstract (Originalsprache)
Primary brain tumors are life‐threatening diseases. Glioblastoma is the most aggressive type with a poor prognosis. Medulloblastoma is the most common pediatric brain tumor. While surgical treatments often result in recurrences owing to the complex nature of the tumor microenvironment, conventional treatments lower the quality of life of patients by causing serious side effects. Therefore, cutting‐edge therapies are required to alleviate patients' burden. Phytochemicals such as curcumin, quercetin, berberine, and resveratrol have been shown as potential therapeutic agents by demonstrating anticancer activity, including the inhibition of cell migration and proliferation, and the induction of apoptosis. This review summarizes the pharmacokinetic and cellular effects of phytochemicals that can be utilized in the treatment of medulloblastoma and glioblastoma by targeting cellular pathways associated with the progression of these diseases. Additionally, the synergistic relationships of these phytochemicals with traditional drugs and the emerging studies that utilize nanotechnology to ensure effective delivery of phytochemicals are covered in this review.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering, Bogazici University, Bebek, Istanbul, Turkiye.
- Department of Biomedical Engineering, Bogazici University, Uskudar, Istanbul, Turkiye.
ORCID-Profile: Ilkay Irem Ozbek, Mesra Aktas, Hale Saybasili, Kutlu O Ulgen
Förderung
- Bogazici University Research Fund
Zitieren
APA
Ozbek, I. I., Aktas, M., Saybasili, H., & Ulgen, K. O. (2026). Harnessing Phytochemicals for Brain Cancer Therapy: Insights Into Medulloblastoma and Glioblastoma Treatment. Phytochemical Analysis. https://doi.org/10.1002/pca.70067
Vancouver
Ozbek II, Aktas M, Saybasili H, Ulgen KO. Harnessing Phytochemicals for Brain Cancer Therapy: Insights Into Medulloblastoma and Glioblastoma Treatment. Phytochemical Analysis. 2026. doi:10.1002/pca.70067
BibTeX
@article{Ozbek2026,
author = {Ozbek, Ilkay Irem and Aktas, Mesra and Saybasili, Hale and Ulgen, Kutlu O},
title = {Harnessing Phytochemicals for Brain Cancer Therapy: Insights Into Medulloblastoma and Glioblastoma Treatment},
journal = {Phytochemical Analysis},
year = {2026},
doi = {10.1002/pca.70067}
}
EUVIMED